Grossberg SE - Search Results

1

Absence of biological effects of orally administered interferon-beta ser.

Witt PL, Goldstein D, Storer BE, Grossberg SE, Flashner M, Colby CB, Borden EC. Witt PL, et al. Among authors: grossberg se. J Interferon Res. 1992 Dec;12(6):411-3. doi: 10.1089/jir.1992.12.411. J Interferon Res. 1992. PMID: 1289408

2

Phase I trial of an oral immunomodulator and interferon inducer in cancer patients.

Witt PL, Ritch PS, Reding D, McAuliffe TL, Westrick L, Grossberg SE, Borden EC. Witt PL, et al. Among authors: grossberg se. Cancer Res. 1993 Nov 1;53(21):5176-80. Cancer Res. 1993. PMID: 8221654 Clinical Trial.

3

Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.

Schiller JH, Storer B, Witt PL, Nelson B, Brown RR, Horisberger M, Grossberg S, Borden EC. Schiller JH, et al. Cancer Res. 1990 Aug 1;50(15):4588-94. Cancer Res. 1990. PMID: 2114942

4

Lack of interferon production by dipyridamole.

Havlin KA, Inglot AD, Willson JK, Borden EC, Grossberg S, Szulc B, Gladysz A, Groehlich B. Havlin KA, et al. J Interferon Res. 1988 Apr;8(2):135-6. doi: 10.1089/jir.1988.8.135. J Interferon Res. 1988. PMID: 3379323

5

Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping.

Redlich PN, Hoeprich PD Jr, Colby CB, Grossberg SE. Redlich PN, et al. Among authors: grossberg se. Proc Natl Acad Sci U S A. 1991 May 1;88(9):4040-4. doi: 10.1073/pnas.88.9.4040. Proc Natl Acad Sci U S A. 1991. PMID: 1708891 Free PMC article.

6

Biological and clinical effects of the oral immunomodulator 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride in patients with malignancy.

Litton GJ, Hong R, Grossberg SE, Vechlekar D, Goodavish CN, Borden EC. Litton GJ, et al. Among authors: grossberg se. J Biol Response Mod. 1990 Feb;9(1):61-70. J Biol Response Mod. 1990. PMID: 1690788

7

Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy.

Ritch PS, Keever C, Schiller J, Rivkin S, Witt PL, Grossberg SE, Truitt RL, Burris H, von Hoff DD, Vaickus L, et al. Ritch PS, et al. Among authors: grossberg se. Ann N Y Acad Sci. 1995 Jul 21;762:359-60. doi: 10.1111/j.1749-6632.1995.tb32340.x. Ann N Y Acad Sci. 1995. PMID: 7668536 Clinical Trial. No abstract available.

8

Frequency and magnitude of interferon β neutralizing antibodies in the evaluation of interferon β immunogenicity in patients with multiple sclerosis.

Grossberg SE, Oger J, Grossberg LD, Gehchan A, Klein JP. Grossberg SE, et al. J Interferon Cytokine Res. 2011 Mar;31(3):337-44. doi: 10.1089/jir.2010.0038. Epub 2011 Jan 12. J Interferon Cytokine Res. 2011. PMID: 21226608

9

High levels of circulating neutralizing antibody in normal animals to recombinant mouse interferon-beta produced in yeast.

Sedmak JJ, Grossberg SE. Sedmak JJ, et al. Among authors: grossberg se. J Interferon Res. 1989 Sep;9 Suppl 1:S61-5. J Interferon Res. 1989. PMID: 2809279

10

Inhibitory effects of mitochondrial metabolic inhibitors on interferon action.

Richtsmeier WJ, Grossberg SE. Richtsmeier WJ, et al. Among authors: grossberg se. J Interferon Res. 1989 Feb;9(1):87-96. doi: 10.1089/jir.1989.9.87. J Interferon Res. 1989. PMID: 2469744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters